Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
BlackSky Technology
BKSY
$800M
| $6.34M | ﹤0.01% |
251,840
-11,559
| -4% | -$276K |
|
|
KREF
2302
KKR Real Estate Finance Trust
KREF
$472M
| $6.32M | ﹤0.01% |
1,033,299
+30,350
| +3% | +$222K |
|
2303
Arbutus Biopharma
ABUS
$865M
| $6.31M | ﹤0.01% |
1,401,157
-161,108
| -10% | -$704K |
|
|
SII
2304
Sprott
SII
$2.65B
| $6.3M | ﹤0.01% |
44,312
+14,664
| +49% | +$1.96M |
|
2305
iRadimed
IRMD
$1.21B
| $6.3M | ﹤0.01% |
65,440
-2,780
| -4% | -$278K |
|
|
MRX
2306
Marex Group Limited Ordinary Shares
MRX
$4.72B
| $6.3M | ﹤0.01% |
141,210
-6,281
| -4% | -$248K |
|
2307
Amphastar Pharmaceuticals
AMPH
$825M
| $6.29M | ﹤0.01% |
321,039
-29,668
| -8% | -$726K |
|
2308
Preformed Line Products
PLPC
$1.52B
| $6.28M | ﹤0.01% |
23,184
-3,289
| -12% | -$841K |
|
2309
MannKind Corp
MNKD
$1.28B
| $6.25M | ﹤0.01% |
2,549,067
-15,459
| -0.6% | -$69K |
|
2310
Savara
SVRA
$1.13B
| $6.23M | ﹤0.01% |
1,140,244
-21,428
| -2% | -$119K |
|
|
SAIL
2311
SailPoint Inc
SAIL
$8.48B
| $6.22M | ﹤0.01% |
469,621
+35,786
| +8% | +$559K |
|
|
MANE
2312
Veradermics Inc
MANE
$4.58B
| $6.19M | ﹤0.01% |
+98,009
| New | +$4.94M |
|
2313
GrafTech
EAF
$194M
| $6.18M | ﹤0.01% |
911,962
-210,760
| -19% | -$2.23M |
|
2314
Heritage Insurance Holdings
HRTG
$842M
| $6.16M | ﹤0.01% |
234,637
-20,537
| -8% | -$542K |
|
2315
Cullinan Oncology
CGEM
$1.05B
| $6.15M | ﹤0.01% |
432,893
-3,380
| -0.8% | -$43.4K |
|
2316
Omeros
OMER
$709M
| $6.15M | ﹤0.01% |
582,512
-10,710
| -2% | -$126K |
|
2317
uniQure
QURE
$2.68B
| $6.15M | ﹤0.01% |
375,852
+12,974
| +4% | +$263K |
|
2318
Lindblad Expeditions
LIND
$1.76B
| $6.14M | ﹤0.01% |
355,189
+35,176
| +11% | +$625K |
|
2319
Lightwave Logic
LWLG
$932M
| $6.13M | ﹤0.01% |
871,344
+104,339
| +14% | +$495K |
|
2320
Ferrari
RACE
$63.3B
| $6.12M | ﹤0.01% |
18,080
+2,960
| +20% | +$1.04M |
|
2321
Annexon
ANNX
$855M
| $6.11M | ﹤0.01% |
1,102,445
+45,385
| +4% | +$255K |
|
2322
Village Super Market
VLGEA
$631M
| $6.1M | ﹤0.01% |
144,387
-30,105
| -17% | -$1.15M |
|
|
UHT
2323
Universal Health Realty Income Trust
UHT
$608M
| $6.08M | ﹤0.01% |
150,214
+19,266
| +15% | +$799K |
|
2324
FerroAtlántica
GSM
$628M
| $6.08M | ﹤0.01% |
1,475,448
-122,604
| -8% | -$591K |
|
2325
First Community Bankshares
FCBC
$915M
| $6.07M | ﹤0.01% |
146,224
+2,272
| +2% | +$86.5K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.